Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice

Diabetes

Volumn 45, Issue 6, 1996, Pages 812-817

  Hultgren, Bruce ^a   Huang, Xiaojian ^a   Dybdal, Noel ^a   Stewart, Timothy A ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC MODEL; HELPER CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0029948898     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.6.812     Document Type: Article

References (47)

1. Muir A, Schatz DA, Maclaren NK: The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus. Endocrinol Metab Clin North Am 21:199-219, 1992
2. Castano L, Eisenbarth GS: Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Ann Rev Immunol 8:647-679, 1990
3. Rossini AA, Handler ES, Greiner DL, Mordes JP: Insulin dependent diabetes mellitus hypothesis of autoimmunity. Autoimmunity 8:221-235, 1991
4. Roep BO, Ardern SD, de Vries RRP, Hutton JC: T cell clones from a type I diabetes patient respond to insulin secretory granule proteins. Nature 345:632-634, 1990
5. Harrison LC, DeAizpurua H, Loudovaris T, Campbell IL, Cebon JS, Tait BD, Colman PG: Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes 40:1128-1133, 1991
6. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu D-F, Erlander MG, Tobin AJ, Maclaren NK: Response of peripheral blood mononuclear cells to glutamine decarboxylase in insulin-dependent diabetes. Lancet 339:458-459, 1992
7. Koevary S, Rossini A, Stoller W, Chick W, Williams RM: Passive transfer of diabetes in the BB/W rat. Science 220:727-728, 1983
8. Like AA, Weringer EJ, Holdash A, McGill P, Atkinson D, Rossini A: Adoptive transfer of autoimmune diabetes mellitus in biobreeding/ Worcester (BB/W) inbred and hybrid rats. J Immunol 134:1583-1587, 1985
9. Bendelac A, Carnaud C, Boitard C, Bach JF: Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-24- T cell. J Exp Med 166:823-832, 1987
10. Wicker LS, Miller BJ, Mullen Y: Transfer of autoimmune diabetes mellitus with splenocytes from non obese diabetic (NOD) mice. Diabetes 35:855-860, 1986
11. Peterson JD, Pike B, McDuffie M, Haskins K: Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice. J Immunol 153:2800-2806, 1994
12. Baxter AG, Adams MA, Mandel TE: Comparison of high- and low-diabetes incidence NOD mouse strains. Diabetes 38:1296-1300, 1989
13. Higuchi Y, Herrera P, Muniesa P, Huarte J, Belin D, Ohashi P, Aichele P, Orci L, Vassalli JD, Vassalli P: Expression of a tumor necrosis factor alpha transgene in murine pancreatic β-cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med 176:1719-1731, 1992
14. Heath WR, Allison J, Hoffmann MW, Schonrich G, Hammerling G, Arnold B, Miller JF: Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 359:547-549, 1992
15. Picarella DE, Kratz A, Li CB, Ruddle NH, Flavell RA: Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes: distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol 150:4136-4150, 1993
16. Bottazzo GF, Dean BM, McNally GM, McKay EH, Swift PGF, Gamble DR: In situ characterization of autoimmune phenomena in the pancreas in diabetic insulitis. N Engl J Med 353:360-363, 1985
17. Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernández-Figueras MT, Ariza A, Gomis R, Bragado R, Martî M, Jaraquemada D, Pujol-Borrell R: Pancreas in recent onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor Vβ usage, and cytokine profile. J Immunol 153:1360-1372, 1994
18. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357, 1986
19. Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7:145-173 1989
20. De Carli M, D'Elios MM, Zancuoghi G, Romagnani S, Del Prete G: Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity 18:301-308, 1994
21. Baekkeskov SH, Jan-Aanstoot H, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesin, De-Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA synthesizing enzyme glutamate decarboxylase. Nature 347:151-156, 1990
22. Harrison LC, Honeyman MC, De Aizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes Lancet 341:1365-1369, 1993
23. Yu L, Gianani R, Eisenbarth GS: Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type I diabetes. Diabetes 43:1229-1233, 1994
24. Svetic A, Jian YC, Lu P, Finkelman FD, Gause WC: Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells. Int Immunol 5:877-883, 1993
25. Wang Z-E, Reiner SL, Zheng S, Dalton DK, Locksley RM: CD4+ effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leismania major. J Exp Med 179:1367-1371, 1984
26. Debray-Sachs M, Carnaud C, Boitard C, Cohen H, Gresser I, Bedossa P, Bach J-F: Prevention of Diabetes in NOD Mice Treated with Antibody of Murine IFNγ. J Autoimmunity 4:237-248, 1991
27. Campbell IL, Kay TW, Oxbrow L, Harrison LC: Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87:739-742, 1991
28. Bucy RP, Hanto DW, Berens E, Schreiber RD: Lack of an obligate role for IFN-g in the primary in vitro mixed lymphocyte response. J Immunol 1148-1152, 1988
29. Maraskovsky E, Chen WF, Shortman K: IL-2 and IFN-g are two necessary lymphokines in the development of cytolytic T cells. J Immunol 143: 1210-1214, 1989
30. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes Science. 259:1739-1742, 1993
31. Huang X, Hultgren B, Dybdal N, Stewart TA: Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity 1:469-478, 1994
32. Katz J, Benoist C, Mathis D: Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol 23:3358-3360, 1993
33. Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC: Major histocompatibility complex class I-deficient NOD-B2 mnull mice are diabetes and insulitis resistant. Diabetes 43:505-509, 1994
34. Wicker LS, Leiter EH, Todd JA, Renjilian RJ, Peterson E, Fischer PA, Podolin PL, Zyistra M, Jaenisch R, Peterson LB: Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes Diabetes 43:500-504, 1994
35. Sumida T, Furukawa M, Sakamoto A, Namekawa T, Maeda T, Zijlstra M, Iwamoto I, Koike T, Yoshida S, Tomioka H: Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Int Immunol 6:1445-1449, 1994
36. Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Braciale TJ: Response to influenza infection in mice with a targeted disruption in the interferon g gene. J Exp Med 178:1725-1732, 1993
37. Shehadeh NN, LaRosa F, Lafferty KJ: Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmunity 6:291-300, 1993
38. Rabinovitch A, Sorensen O, Suarez-Pinzon WL, Power RF, Rajotte RV, Bleackley RC: Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon gamma mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia 37:833-837, 1994
39. Muir A, Peck A, Clare-Salzler M, Song YH, Cornelius J, Luchetta R, Krischer J, Maclaren N: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 95:628-634, 1995
40. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL: Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178:87-99, 1993
41. Pennline KJ, Roque-Gaffney E, Monahan M: Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopath 71:169-175, 1994
42. Moritani M, Yoshimoto K, Tashiro F, Hashimoto C, Miyazaki J, Ii S, Kudo E, Iwahana H, Hayashi Y, Sano T: Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int Immunol 6:1927-1936, 1994
43. Wogensen L, Lee MS, Sarvetnick N: Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β-cells in nonobese diabetic mice. J Exp Med 179:1379-1384, 1994
44. Wynn TA, Jakovic D, Hieny S, Zioncheck K, Jardieu P, Cheever AW, Sher A: IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J Immunol 154:3999-4009, 1995
45. Amiri P, Haak-Frendscho M, Robbins K, McKerrow JH, Stewart T, Jardieu P: Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon γ knockout mice. J Exp Med 180:43-51, 1994
46. Larsen CP, Ritchie SC, Hendrix R, Linsley PS, Hathcock KS, Hodes RJ, Lowry RP, Pearson TC: Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 152:5208-5219, 1994
47. Thompson CB: Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81:979-982, 1995